These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32298007)

  • 1. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
    Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I
    Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
    Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
    Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
    Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
    Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular damage and worsening renal function in chronic heart failure.
    Damman K; Masson S; Hillege HL; Voors AA; van Veldhuisen DJ; Rossignol P; Proietti G; Barbuzzi S; Nicolosi GL; Tavazzi L; Maggioni AP; Latini R
    JACC Heart Fail; 2013 Oct; 1(5):417-24. PubMed ID: 24621973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
    Damman K; Van Veldhuisen DJ; Navis G; Vaidya VS; Smilde TD; Westenbrink BD; Bonventre JV; Voors AA; Hillege HL
    Heart; 2010 Aug; 96(16):1297-302. PubMed ID: 20659949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.
    Rao VS; Ahmad T; Brisco-Bacik MA; Bonventre JV; Wilson FP; Siew ED; Felker GM; Anstrom KK; Mahoney DD; Bart BA; Tang WHW; Velazquez EJ; Testani JM
    Circ Heart Fail; 2019 Jun; 12(6):e005552. PubMed ID: 31163974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
    Maeder MT; Rickli H; Pfisterer ME; Muzzarelli S; Ammann P; Fehr T; Hack D; Weilenmann D; Dieterle T; Kiencke S; Estlinbaum W; Brunner-La Rocca HP;
    Am Heart J; 2012 Mar; 163(3):407-14, 414.e1. PubMed ID: 22424011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Emmens JE; Ter Maaten JM; Matsue Y; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; Todd J; van Veldhuisen DJ; Hillege HL; Damman K; van der Meer P; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):641-9. PubMed ID: 26511274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening renal function during hospitalization in elderly patients with heart failure: an independent factor of activities of daily living decline.
    Kubo I; Izawa KP; Kajisa N; Ryu M; Akasaka H; Ogura A; Kanai M; Matsuzoe H; Matsumoto D
    Heart Vessels; 2021 Jan; 36(1):76-84. PubMed ID: 32720094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of renal tubular damage in chronic heart failure.
    Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
    Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.
    Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Asada T; Fujiwara A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Nishimura K; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
    J Am Heart Assoc; 2019 Sep; 8(17):e011468. PubMed ID: 31441355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Sokolski M; Zymliński R; Biegus J; Siwołowski P; Nawrocka-Millward S; Todd J; Yerramilli MR; Estis J; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2017 Jun; 19(6):760-767. PubMed ID: 28133864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of renal tubular damage, as assessed by urinary β2-microglobulin-creatinine ratio, on cardiac prognosis in patients with chronic heart failure.
    Otaki Y; Watanabe T; Shishido T; Takahashi H; Funayama A; Narumi T; Kadowaki S; Hasegawa H; Honda S; Netsu S; Ishino M; Arimoto T; Miyashita T; Miyamoto T; Konta T; Kubota I
    Circ Heart Fail; 2013 Jul; 6(4):662-8. PubMed ID: 23674363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of worsening renal function related to medication in heart failure.
    Brunner-La Rocca HP; Knackstedt C; Eurlings L; Rolny V; Krause F; Pfisterer ME; Tobler D; Rickenbacher P; Maeder MT;
    Eur J Heart Fail; 2015 Feb; 17(2):159-68. PubMed ID: 25808849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.
    Emmens JE; Ter Maaten JM; Damman K; van Veldhuisen DJ; de Boer RA; Struck J; Bergmann A; Sama IE; Streng KW; Anker SD; Dickstein K; Lang CC; Metra M; Samani NJ; Ng LL; Voors AA
    Circ Heart Fail; 2019 May; 12(5):e005544. PubMed ID: 31091993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
    Brisco MA; Zile MR; Hanberg JS; Wilson FP; Parikh CR; Coca SG; Tang WH; Testani JM
    J Card Fail; 2016 Oct; 22(10):753-60. PubMed ID: 27374839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.